SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals - Quaterly Results

22 May 2024 Evaluate
The sales figure stood at Rs. 656.40 millions for the March 2024 quarter. The mentioned figure indicates a growth of about 28.78% as compared to Rs. 509.70 millions during the year-ago period.The Net Profit of the company slipped to Rs. 30.70 millions from Rs. 92.90 millions, a decline of -66.95% on QoQ basis.The company reported a degrowth in operating Profit to 69.80 millions from 135.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 656.40 509.70 28.78 2541.60 2179.80 16.60 2541.60 2179.80 16.60
Other Income 32.40 69.60 -53.45 119.50 188.40 -36.57 119.50 188.40 -36.57
PBIDT 69.80 135.50 -48.49 403.90 402.10 0.45 403.90 402.10 0.45
Interest 10.90 8.00 36.25 31.90 21.90 45.66 31.90 21.90 45.66
PBDT 58.90 127.50 -53.80 372.00 380.20 -2.16 372.00 380.20 -2.16
Depreciation 16.10 14.30 12.59 64.00 58.50 9.40 64.00 58.50 9.40
PBT 42.80 113.20 -62.19 308.00 321.70 -4.26 308.00 321.70 -4.26
TAX 12.10 20.30 -40.39 82.10 78.30 4.85 82.10 78.30 4.85
Deferred Tax -3.90 -7.30 -46.58 -4.50 -5.70 -21.05 -4.50 -5.70 -21.05
PAT 30.70 92.90 -66.95 225.90 243.40 -7.19 225.90 243.40 -7.19
Equity 58.20 57.70 0.87 58.20 57.70 0.87 58.20 57.70 0.87
PBIDTM(%) 10.63 26.58 -60.00 15.89 18.45 -13.85 15.89 18.45 -13.85

Bharat Parenterals Share Price

1213.10 32.30 (2.74%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×